logo-loader
Revive Therapeutics - Revive Therapeutics: Analyst sees 'substantial upside potential' as key assets move towards clinic
1 week, 1 day ago
health
1 week, 1 day ago
Open Orphan PLC -
1 week, 6 days ago
healthcare
2 weeks ago
healthcare
on 14/5/20
Open Orphan PLC - Open Orphan PLC: 'Rapidly scaling up and building out higher value, longer term contracts'
on 14/5/20
MaxCyte Inc - MaxCyte deal with Caribou 'demonstrates expertise and value' of its Flow Electroporation technology
on 11/5/20
Biosciences
on 7/5/20
Shield Therapeutics PLC - Shield Therapeutics: 'US talks ongoing with progress being made'
on 6/5/20
Pharmaceuticals
on 6/5/20
biotech
on 28/4/20
biotech
on 26/3/20
MaxCyte Inc - Maxcyte deal with Allogene Therapeutics 'a clear endorsement' of its technology
on 26/3/20
Shield Therapeutics PLC - Shield Therapeutics extends cash runway into 2021 after significant China deal
on 4/2/20
MaxCyte Inc - MaxCyte in 'exceptional position to benefit from explosive growth in gene therapy'
on 4/2/20
biotech
on 3/2/20
biotechnology
on 28/1/20
MaxCyte Inc - MaxCyte offering exposure to 'explosive growth' in cell therapy and cellular engineering
on 5/12/19
Ipsen - Open Orphan 'continuing to target rapid scale-up and profitability'
on 5/12/19
gene
on 26/11/19